Zurcher Kantonalbank (Zurich Cantonalbank) Sangamo Therapeutics, Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$41.5 Billion
Q3 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 436 shares of SGMO stock, worth $191. This represents 0.0% of its overall portfolio holdings.

Number of Shares

436

Previous 436 -0.0%

Holding current value

$191

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$0.78 - $2.87 $4,430 - $16,301	-5,680 Reduced 92.87%	436 $0
Q3 2024 Nov 07, 2024	SELL	$0.32 - $1.1 $728 - $2,503	-2,276 Reduced 27.12%	6,116 $5,000
Q2 2024 Jul 29, 2024	SELL	$0.36 - $0.65 $518 - $936	-1,440 Reduced 14.65%	8,392 $3,000
Q1 2024 Apr 25, 2024	SELL	$0.42 - $1.38 $128 - $420	-305 Reduced 3.01%	9,832 $6,000
Q4 2023 Jan 30, 2024	SELL	$0.3 - $0.63 $245 - $514	-817 Reduced 7.46%	10,137 $5,000
Q3 2023 Oct 25, 2023	SELL	$0.58 - $1.47 $531 - $1,347	-917 Reduced 7.72%	10,954 $6,000
Q2 2023 Aug 07, 2023	SELL	$1.11 - $1.74 $21,976 - $34,450	-19,799 Reduced 62.52%	11,871 $15,000
Q4 2022 Feb 01, 2023	BUY	$2.77 - $5.07 $16,700 - $30,567	6,029 Added 23.51%	31,670 $99,000
Q3 2022 Nov 09, 2022	SELL	$4.27 - $6.39 $994 - $1,488	-233 Reduced 0.9%	25,641 $126,000
Q2 2022 Aug 09, 2022	SELL	$3.28 - $6.21 $4,483 - $8,489	-1,367 Reduced 5.02%	25,874 $107,000
Q1 2022 Apr 21, 2022	SELL	$5.23 - $7.82 $18,660 - $27,901	-3,568 Reduced 11.58%	27,241 $158,000
Q4 2021 Feb 01, 2022	SELL	$7.29 - $10.97 $4,344 - $6,538	-596 Reduced 1.9%	30,809 $231,000
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $180 - $240	20 Added 0.06%	31,405 $283,000
Q2 2021 Jul 30, 2021	BUY	$10.17 - $12.64 $9,142 - $11,363	899 Added 2.95%	31,385 $376,000
Q1 2021 May 03, 2021	BUY	$10.88 - $17.05 $153,136 - $239,978	14,075 Added 85.77%	30,486 $382,000
Q2 2020 Jul 28, 2020	BUY	$6.21 - $11.83 $18,220 - $34,709	2,934 Added 21.77%	16,411 $147,000
Q1 2020 May 06, 2020	BUY	$5.05 - $8.85 $33,279 - $58,321	6,590 Added 95.69%	13,477 $86,000
Q2 2019 Jul 30, 2019	BUY	$8.75 - $13.03 $2,353 - $3,505	269 Added 4.06%	6,887 $74,000
Q1 2019 Apr 29, 2019	SELL	$7.72 - $12.81 $1,304 - $2,164	-169 Reduced 2.49%	6,618 $63,000
Q4 2018 Jan 25, 2019	BUY	$9.51 - $16.6 $14,759 - $25,763	1,552 Added 29.65%	6,787 $78,000
Q3 2018 Nov 09, 2018	BUY	$13.05 - $19.05 $6,838 - $9,982	524 Added 11.12%	5,235 $89,000
Q4 2017 Jan 31, 2018	BUY	$11.6 - $17.35 $27,422 - $41,015	2,364 Added 100.72%	4,711 $77,000
Q3 2017 Nov 08, 2017	BUY	$8.4 - $15.0 $19,714 - $35,205	2,347	2,347 $35,000

Others Institutions Holding SGMO

# of Institutions

124

Shares Held

62.5M

Call Options Held

953K

Put Options Held

1.11M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $68.9M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Sangamo Therapeutics, Inc Transaction History